TickerFactsScreenerDevelopers

Inmune Bio, Inc. (INMB) — Operating Income

Annual figures by fiscal year, from SEC filings.

2017: -$981.5K2018: -$12.44M2019: -$7.76M2020: -$12.23M2021: -$29.15M2022: -$25.95M2023: -$29.74M2024: -$42.63M2025: -$47.38M-$47.38M
2017Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$47.38M-11.1%
2024-$42.63M-43.4%
2023-$29.74M-14.6%
2022-$25.95M+11.0%
2021-$29.15M-138.4%
2020-$12.23M-57.7%
2019-$7.76M+37.7%
2018-$12.44M-1167.5%
2017-$981.5K—